News & Events2018-11-02T15:00:35+00:00

News & Events

Observations, opinions, and opportunities presented by our experts

ALL
NEWS
THOUGHT LEADERSHIP
EVENTS

PHE’s Baumgardner to Present on CAR-T Therapy Outcomes at ASH

Senior Research Economist James Baumgardner will be presenting “CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments” at the American Society of Hematology (ASH) 60thAnnual Meeting and Exposition, taking place from December 1-4 in San Diego, CA.

[…]

Precision-Led Working Group Provides Suggestions to Close Gaps When Creating Value Frameworks for New Medical Therapies

Randomized controlled trials don’t capture real-world evidence regarding how patients will actually interact with, adhere to, or find value in a costly new medical therapy, yet current value frameworks and assessments don’t include this “real world” element. A new working group led by PHE’s Anupam Jena, Jacki Chou, and Darius Lakdawalla aim to improve this dynamic by offering guidance on closing the gap between real-world and clinical trial data when formulating value frameworks.

[…]

Precision Xtract Taps Industry Leader Zac Stillerman as New President & General Manager

 

VETERAN STRATEGIST CHOSEN TO LEAD INNOVATIVE HEALTH ECONOMICS,
MARKET ACCESS, AND PAYER ANALYTICS CONSULTANCY  

Bethesda, MD – November 7, 2018 – Precision Xtract, part of Precision Value & Health, today announced Zac Stillerman, acclaimed healthcare industry operator and strategist, as new president and general manager. Responsible for leading Precision Xtract through its next phase of growth, Stillerman has a proven ability to translate vision and strategy into dynamic collaboration and first-class execution. He joins Precision Xtract at a time of growing demand from innovative life sciences companies for essential consulting activities, […]

Rapid Diagnostics for Rheumatoid Arthritis Study Published in Journal of Medical Economics Article

PHE recently published a new study in collaboration with Genalyte on the potential value of rapid, cloud-enabled, onsite laboratory testing for the diagnosis of rheumatoid arthritis. The study found that this technology could generate value of over $5,000 per evaluated patient-year. The study was led by PHE’s Kata Bognar, Jason Shafrin, Michelle Brauer, Lauren Zhao, and Bapu Jena. […]

Load More Posts
LOAD MORE

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK